Finally, the lack of an increase in serum E-selectin in our COVID-19 patients suggests that the endothelial damage in these patients is a less relevant, secondary event caused by monocyte (as confirmed by the increase in serum MCP-2) and platelet recruitment (as confirmed by the increased P-selectin values). This evidence concerns the gene CCL8 and COVID-19.